Preferred Label : imdevimab;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3344843/fr/ronapreve-casirivimab-/-imdevimab-prevention-de-la-covid-19
2022
false
false
false
France
COVID-19
casirivimab and imdevimab
treatment outcome
insurance, health, reimbursement
Post-Exposure prophylaxis
adult
adolescent
antiviral agents
evaluation of the transparency committee
COVID-19
casirivimab
casirivimab and imdevimab drug combination
imdevimab

---
https://www.has-sante.fr/jcms/p_3318295/fr/ronapreve-casirivimab-imdevimab
https://www.has-sante.fr/jcms/p_3318291/fr/decision-n-2022-0066/dc/sem-du-17-fevrier-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ronapreve
2022
false
false
false
France
casirivimab and imdevimab
evaluation of the transparency committee
casirivimab
imdevimab
casirivimab and imdevimab drug combination

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.